🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Kenvue Inc. KVUE SPX

Consumer Defensive · Household & Personal Products · United States
https://www.kenvue.com

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

READ MORE ›
$17.28
-24.24% 1Y

Market & Price

Market Cap
$33.18B
Current Price
$17.28
High / Low (52W)
$22.81 / $13.61
Beta
0.52

Valuation

Stock P/E
20.57
Industry PE
18.88
Forward P/E
13.97
PEG Ratio
1.48
Book Value
$5.53
Price to Book
3.13
P/S
2.17
EV/EBITDA
11.79
Dividend Yield
4.80%

Profitability & Returns

ROCE
11.49%
ROE
15.70%
ROA
7.07%
Profit Margin
10.61%
Op Margin
21.62%
EPS (Latest Qtr)
$0.25
EPS (TTM)
$0.84

Balance Sheet & Liquidity

Debt/Equity
0.83
Quick Ratio
0.61
Current Ratio
0.98
Debt
$8.80B
Total Assets
$27.08B
Current Assets
$5.70B
Working Capital
$-248.00M

Ownership

Promoter Holding
0.05%
Chg in Prom Hold
-
FII / Inst Holding
95.44%
Chg in FII Hold
-0.00%

Financial Snapshot

Enterprise Value
$40.90B
Total Revenue (TTM)
$15.29B
EBITDA
$3.47B
Free Cash Flow
$1.86B
Operating Cash Flow
$2.26B
Shares Outstanding
1.92B
Gross Margin
58.60%
Payout Ratio
98.51%

Growth (CAGR)

Revenue 5Y
0.39%
Profit 5Y
-10.70%
Revenue (YoY)
4.50%
Earnings (YoY)
46.90%

PROS

  • Attractive dividend yield of 4.80%.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Earnings shrank at -10.7% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 KVUE Kenvue Inc. SPX 17.28 20.57 $33.18B 4.80% 11.49% 15.70% 0.39% -10.70%
2 WMT Walmart Inc. SPX 115.75 40.76 $922.64B 0.86% 18.21% 24.13% 5.27% 23.30%
3 COST Costco Wholesale Corporation NDXSPX 956.32 49.76 $424.27B 0.61% 27.44% 29.65% 6.64% 11.49%
4 KO The Coca-Cola Company SPX 79.01 24.85 $339.94B 2.68% 21.13% 43.37% 3.69% 11.16%
5 PG The Procter & Gamble Company SPX 143.56 21.02 $334.29B 2.97% 23.63% 31.11% 1.67% 2.71%
6 PM Philip Morris International Inc. SPX 177.38 24.98 $276.46B 3.31% 35.35% - 8.57% 7.84%
7 PEP PepsiCo, Inc. NDXSPX 144.19 22.64 $197.10B 4.11% 15.23% 43.88% 2.83% -2.57%
8 MO Altria Group, Inc. SPX 69.58 14.53 $116.19B 6.09% 40.85% - -0.89% 6.42%
9 MNST Monster Beverage Corporation NDXSPX 88.08 42.55 $86.14B - 28.33% 26.65% 9.54% 16.94%
⚙Ad space

Quarterly Results

Figures in USD.

Metric Apr 2022Jul 2022Oct 2022Jan 2023Apr 2023Jul 2023Oct 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 3.59B3.80B3.79B3.77B3.85B4.01B3.92B3.67B3.89B4.00B--3.74B3.84B3.76B3.78B3.91B
Cost of Revenue ------------1.57B1.58B1.54B1.64B1.61B
Gross Profit 1.96B2.16B2.12B2.05B2.12B2.23B2.25B2.04B2.24B2.37B--2.17B2.26B2.23B2.14B2.30B
Operating Expenses ------------1.55B1.51B1.51B1.50B1.46B
Operating Income 611.00M770.00M763.00M-640.00M702.00M710.00M-550.00M154.00M--618.00M752.00M713.00M632.00M838.00M
EBITDA ------------701.00M837.00M774.00M674.00M921.00M
Interest Expense ------------107.00M107.00M107.00M109.00M106.00M
Pretax Income ------------458.00M588.00M526.00M427.00M672.00M
Tax Provision ------------136.00M168.00M128.00M97.00M198.00M
Net Income 512.00M605.00M586.00M361.00M469.00M430.00M438.00M327.00M296.00M58.00M--322.00M420.00M398.00M330.00M474.00M
Diluted EPS 0.300.350.340.210.270.230.230.170.150.03--0.170.220.210.170.25
R&D Expense 88.00M94.00M90.00M-89.00M99.00M78.00M-100.00M105.00M97.00M-99.00M91.00M94.00M-84.00M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2021Jan 2022Dec 2022Jan 2023Dec 2023Dec 2024Dec 2025
Revenue -15.05B14.95B14.95B15.44B15.46B15.12B
Cost of Revenue --6.67B-6.80B6.50B6.33B
Gross Profit -8.42B8.29B8.29B8.64B8.96B8.79B
Operating Expenses --5.60B-6.15B6.33B6.08B
Operating Income -2.92B2.69B2.67B2.49B2.63B2.71B
EBITDA --3.28B-3.17B2.47B2.99B
Interest Expense --0-358.00M431.00M430.00M
Pretax Income --2.64B-2.19B1.42B2.00B
Tax Provision --573.00M-526.00M385.00M529.00M
Net Income -2.08B2.06B2.06B1.66B1.03B1.47B
Diluted EPS -1.211.091.200.900.540.76
R&D Expense -355.00M-375.00M399.00M408.00M382.00M

Compounded Sales Growth

5 Years:0.39%
1 Year:4.50%

Compounded Profit Growth

5 Years:-10.70%
1 Year:46.90%

Stock Price Performance

1 Year:-24.24%
6 Months:+3.87%
3 Months:-8.53%
1 Month:+1.50%

Balance Sheet (Annual)

Figures in USD.

Metric Jan 2021Dec 2021Jan 2022Dec 2022Jan 2023May 2023Dec 2023Dec 2024Dec 2025
Total Assets ---27.32B27.32B-27.85B25.60B27.08B
Current Assets ---5.88B--6.14B5.53B5.70B
Cash & Equivalents ---1.23B1.23B1.17B1.38B1.07B1.06B
Inventory ---2.23B--1.85B1.59B1.67B
Receivables ---2.12B--2.07B2.17B2.38B
Total Liabilities ---7.35B7.35B-16.64B15.93B16.31B
Current Liabilities ---3.93B3.93B-5.48B5.74B5.95B
Long Term Debt ---8.93B0-7.69B6.94B6.94B
Total Debt ---116.00M--8.43B8.72B8.67B
Total Equity 18.40B-20.49B19.97B19.97B-11.21B9.67B10.77B
Shares Outstanding ---1.89B--1.92B1.92B1.94B

Cash Flows (Annual)

Figures in USD.

Metric Dec 2021Jan 2022Dec 2022Jan 2023Dec 2023Dec 2024Dec 2025
Operating Cash Flow -334.00M2.52B2.52B3.17B1.77B2.20B
Investing Cash Flow --171.00M-390.00M-390.00M-488.00M-425.00M-436.00M
Financing Cash Flow -0-1.58B-1.58B-2.53B-1.56B-1.84B
Capital Expenditure --295.00M-375.00M-375.00M-469.00M-434.00M-475.00M
Free Cash Flow -39.00M2.15B2.15B2.70B1.33B1.72B
Net Change in Cash --552.00M-153.00M-221.00M-76.00M
Share Buybacks ---07.00M235.00M197.00M
Dividends Paid -0-0766.00M1.55B1.58B

Ratios (Annual)

Figures in %.

Metric Dec 2021Jan 2022Dec 2022Jan 2023Dec 2023Dec 2024Dec 2025
Gross Margin % -55.9%55.4%55.4%56.0%58.0%58.1%
Operating Margin % -19.4%18.0%17.9%16.1%17.0%18.0%
Net Margin % -13.8%13.8%13.8%10.8%6.7%9.7%
ROE % -10.1%10.3%10.3%14.8%10.7%13.7%
ROCE % --11.5%11.4%11.1%13.2%12.8%

Shareholding Pattern

Insiders
0.05%
Institutions
95.44%
Public Float
95.49%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 7.57% 145.30M $2.51B
2 FMR, LLC 7.04% 135.09M $2.33B
3 Vanguard Capital Management LLC 6.48% 124.42M $2.15B
4 State Street Corporation 6.23% 119.57M $2.07B
5 Vanguard Portfolio Management LLC 4.82% 92.46M $1.60B
6 Pentwater Capital Management Lp 2.71% 52.00M $898.56M
7 Geode Capital Management, LLC 2.67% 51.27M $885.95M
8 Massachusetts Financial Services Co. 2.59% 49.74M $859.58M
9 Independent Franchise Partners, LLP 2.56% 49.21M $850.33M
10 Millennium Management Llc 1.66% 31.80M $549.53M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for KVUE

No recent headlines available.

Explore More

📊 Consumer Defensive Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space